Where is Tempus located?

Tempus is located in Chicago, United States .

Who is the current CEO of Tempus?

Eric Lefkofsky is the current CEO of Tempus.

How many employees does Tempus have?

Tempus has 772 employees as of Dec 31, 2022.

When was the latest funding round of Tempus?

Tempus's latest funding round was on Oct 20, 2022.

What is the annual revenue of Tempus?

Annual revenue of Tempus is €571K as on Dec 31, 2023.

Is Tempus a Healthcare IT company?

The primary sector of Tempus is Healthcare IT.

Where does Tempus rank among its competitors?

Tempus ranks 1 amongst 27 active competitors.

Who are the top competitors of Tempus?

Tempus' top competitors are Personalis, CancerIQ and Artera.

Tempus - 2025 Company Profile, Funding & Competitors - Tracxn

Tempus is a public company based in Chicago (United States), founded in 2015 by Eric Lefkofsky. It operates as an AI-based precision medicine solutions for oncology. Tempus has raised $1.05B in funding from investors like New Enterprise Associates, T. Rowe Price and Revolution. The company has 27 active competitors, including 10 funded and 3 that have exited. Its top competitors include companies like Personalis, CancerIQ and Artera.

Sectors and market segments that Tempus operate in

Tempus serves in the B2B, SaaS space in the HealthTech market segments.The primary business model of Tempus is:

HealthTech > Healthcare IT > ***** **** > ***** ******

Company Details

AI-based precision medicine solutions for oncology. It provide an informatics platform for cancer treatment that helps physicians to make decisions based on computational analysis of a patient’s pathology. The platform analyzes a patient’s genetic data in the context of molecular therapies. The company connects bioinformatics with anatomical pathology providing doctors with relevant insight to make oncological decisions and more.

Website: www.tempus.com/
Social
Email ID: *****@tempus.com

Key Metrics

Founded Year

2015

Location

Chicago, United States

Stage

Public

Total Funding

$1.05B in 8 rounds

Latest Funding Round

Series G, Oct 20, 2022, Undisclosed

Investors

New Enterprise Associates & 11 more

Ranked

1^st among 27 active competitors

Annual Revenue

€571K as on Dec 31, 2023

Employee Count

772 as on Dec 31, 2022

Investment & Acquisitions

Deep 6 AI & 4 more

Similar Companies

Personalis & 32 more

Exit Details

Public

Legal entities associated with Tempus

Tempus is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
Tempus AI, Inc. CIN: 20181095311 United States, Active	Jan 31, 2018	-	-
TEMPUS CIN: 40203017317 Latvia, Active	Sep 05, 2016	$618K (as on Dec 31, 2023)	3 (as on Dec 31, 2023)
TEMPUS, LLC CIN: 954834686 United States, Active	Dec 26, 999	-	772 (as on Dec 31, 2022)
TEMPUS INC CIN: 391923550 United States, Active	Dec 31, 2014	-	30 (as on Dec 31, 2022)

Get your free copy of Tempus's company profile

Tempus has raised a total funding of $1.05B over 8 rounds. Its first funding round was on Sep 22, 2017.

Tempus has 12 institutional investors including New Enterprise Associates, T. Rowe Price and Revolution.

Here is the list of recent funding rounds of Tempus:

Date of funding	Funding Amount	Round Name	Post money valuation	Revenue multiple	Investors
Oct 20, 2022	Undisclosed	Series G	-	-	-
Oct 20, 2022	Undisclosed	Conventional Debt	-	-	-
Dec 10, 2020	$200M	Series G	$8.1B	217966.8x	Google, Novo Holdings, Baillie Gifford, Franklin Templeton Investments, T. Rowe Price

Access funding benchmarks and valuations. Sign up today!

View details of Tempus's funding rounds and investors

The founders of Tempus is Eric Lefkofsky. Eric Lefkofsky is the CEO of Tempus. Eric Lefkofsky has founded 7 more companies including Olivia health, Flashtalking and Flashtalking Production.

View details of Tempus's Founder profiles and Board Members

Tempus's employee count trend

Tempus has 772 employees as of Dec 22. The total employee count is 2.0% more than what it was in Dec 21. Here is Tempus's employee count trend over the years:

Uncover Tempus's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Tempus include Personalis, CancerIQ and Artera. Here is the list of Top 10 competitors of Tempus, ranked by Tracxn score:

Overall Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tempus 2015, Chicago (United States), Public	AI-based precision medicine solutions for oncology	$1.05B	T. Rowe Price, Novo Holdings & 10 others	73/100
2nd	Personalis 2011, Menlo Park (United States), Public	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Abingworth, Mohr Davidow Ventures & 4 others	65/100
3rd	CancerIQ 2013, Chicago (United States), Series B	Cloud-based platform to doctors, for identifying cancer risk patients and delivering care plans	$23.9M	Amgen, Lightbank & 11 others	62/100
4th	Artera 2021, Menlo Park (United States), Series A	AI-derived prognostic biomarker test for cancer detection	$135M	EDBI, A&E Investments & 24 others	57/100
5th	Imagene 2020, Tel Aviv (Israel), Series A	Provider of an AI-based cancer diagnosis and precision medicine planning software for healthcare providers	$21.5M	Blumberg Capital, European Union & 4 others	47/100
6th	Perthera 2012, Mclean (United States), Series A	Personalized molecular cancer profiling through genomics and proteomics	$17.8M	Invictus Growth, Pilot Growth Equity	46/100
7th	Genomate Health 2022, Cambridge (United States), Series A	AI-based computational system cancer treatment decisions	$10.4M	STRT	40/100
8th	Trapelo 2009, Fort Myers (United States), Acquired	Provider of precision medicine platform for oncologists	$16.2M	Chrysalis Ventures, Beringea & 3 others	39/100
9th	LinkDoc 2014, Haidian (China), Series D	Provider of the oncology-focused database	$263M	New Enterprise Associates, Temasek & 10 others	38/100
10th	ConcR 2018, London (United Kingdom), Seed	Provides AI-based decision support tools and software for cancer diagnosis and drug designing	$3.07M	Parkwalk, Avonmore Developments & 6 others	34/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Tempus's competitors? Click here to see the top ones

Tempus has not made any investments yet. Tempus has made 5 acquisitions. Here is the list of latest three $acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 11, 2025	Acquisition	Deep 6 AI	2013	Pasadena, United States
Nov 05, 2024	Acquisition	Ambry Genetics	1999	Aliso Viejo, United States
Mar 09, 2023	Acquisition	Mpirik	2011	Milwaukee, United States